Cash conversion at unprecedented 21.5% as cash reserves halved

Operating cash flow fell 79.1% to $0.3M, and OCF/EBITDA conversion came in at 21.5% — an unprecedented low against the supplied four-period historical mean of 81.9% (range 76.5%–87.7%) and the prior comparable's 87.0%. Cash and equivalents halved over the year, falling 50.2% to $4.4M from $8.9M.

Reported P&L weakened on every line. Revenue fell 1.3% to $12.3M, EBITDA dropped 15.6% to $1.5M, PBT fell 20.2% to $0.7M and NPAT fell 24.5% to $0.4M. EBITDA margin compressed to 12.6% (also flagged as an unprecedented low against the 14.7%–17.5% historical range), and the effective tax rate jumped to 34.7% from 31.0% — itself an unprecedented high versus the 27.6% historical mean.

A $0.15 interim dividend was declared. The group remains debt-free.

OCF of $0.3M against EBITDA of $1.5M means the reported earnings number is not converting to spendable cash this period. That is a much sharper signal than the headline NPAT decline because the gap is unprecedented in the supplied historical baseline, not a small drift. For a small-cap with $4.4M of cash and an interim dividend to fund, sustained weakness here would force a question about distribution capacity rather than reported profitability.

Litigation costs explain a large share of the profit decline, not the cash decline. Management discloses that defending a shareholder opposition to a proposed capital return reduced profit by roughly $0.2M, with costs continuing into FY25. Against a PBT decline of $0.2M ($0.7M vs $0.8M), that single item accounts for most of the operating-profit gap. Strip it out, and underlying PBT would have been broadly flat — but the cash-conversion problem would remain.

The tax line distorts the NPAT comparison. The effective tax rate rose to an unprecedented 34.7% from 31.0%, opening a 4.3pp gap between PBT growth (-20.2%) and NPAT growth (-24.5%). PBT is the cleaner operating read this period; the NPAT decline overstates how much the underlying business deteriorated.

The supplied second-half shape from FY24 shows H1 contributing 47.9% of full-year revenue, 51.0% of EBITDA and 43.8% of NPAT — i.e., the prior shape was second-half weighted on profit. Annualising the current run-rate gives implied revenue of roughly $24.6M against an FY24 outturn of $25.9M, which is consistent with a flattish full year if the H2 mix repeats.

That gap matters because management has flagged litigation costs continuing into FY25, which will pressure the H2 profit step-up the historical shape would otherwise support. The release does not state when this overhang ends.

The supplied working-capital movement of -$0.4M sits at the lower edge of the historical range and is, on its own, a modest cash positive — yet OCF still collapsed. That implies cash leakage outside operating working capital (tax payments, lease cash, or other items) rather than a debtor or inventory blow-out, even though debtor days ticked up to 30.9 from 29.8 and inventory days to 10.1 from 7.7.

Two further quality caveats:

• ROE printed at an unprecedented 9.5% versus the 4.7%–7.9% historical range, but total equity contracted 25.4% to $9.3M. Part of the ROE strength is denominator-driven, not earnings-driven.
• Pre-lease FCF swung to -$0.4M from +$1.0M as capex rose 21.4% to $0.7M (5.9% of revenue versus 4.8%). The dividend is not covered by current-period FCF and is being funded from the cash balance, which has already halved.

The litigation drag is genuinely one-off in nature but, on management's own disclosure, will not be one-period.

This briefing cannot assess store-level trading trends or the litigation's expected duration, neither of which is quantified in the disclosed material.